236 related articles for article (PubMed ID: 23846799)
1. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
[TBL] [Abstract][Full Text] [Related]
2. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
Uddin R; Masood F; Azam SS; Wadood A
Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
[TBL] [Abstract][Full Text] [Related]
3. UDP-N-Acetylglucosamine enolpyruvyl transferase (MurA) of Acinetobacter baumannii (AbMurA): Structural and functional properties.
Sonkar A; Shukla H; Shukla R; Kalita J; Pandey T; Tripathi T
Int J Biol Macromol; 2017 Apr; 97():106-114. PubMed ID: 28064057
[TBL] [Abstract][Full Text] [Related]
4. Comparative subtractive proteomics based ranking for antibiotic targets against the dirtiest superbug: Acinetobacter baumannii.
Ahmad S; Raza S; Uddin R; Azam SS
J Mol Graph Model; 2018 Jun; 82():74-92. PubMed ID: 29705560
[TBL] [Abstract][Full Text] [Related]
5. Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii - insights from molecular docking, molecular dynamic simulations and in vitro assays.
Skariyachan S; Manjunath M; Bachappanavar N
J Biomol Struct Dyn; 2019 Mar; 37(5):1146-1169. PubMed ID: 29529934
[TBL] [Abstract][Full Text] [Related]
6. Comparative genomics study for identification of putative drug targets in Salmonella typhi Ty2.
Batool N; Waqar M; Batool S
Gene; 2016 Jan; 576(1 Pt 3):544-59. PubMed ID: 26555890
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive structural and functional characterization of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (Mtb-MurA) and prediction of its accurate binding affinities with inhibitors.
Babajan B; Chaitanya M; Rajsekhar C; Gowsia D; Madhusudhana P; Naveen M; Chitta SK; Anuradha CM
Interdiscip Sci; 2011 Sep; 3(3):204-16. PubMed ID: 21956743
[TBL] [Abstract][Full Text] [Related]
8. Discovery of new MurA inhibitors using induced-fit simulation and docking.
Rožman K; Lešnik S; Brus B; Hrast M; Sova M; Patin D; Barreteau H; Konc J; Janežič D; Gobec S
Bioorg Med Chem Lett; 2017 Feb; 27(4):944-949. PubMed ID: 28077258
[TBL] [Abstract][Full Text] [Related]
9. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K; Khan W; Azam SS; Wadood A
Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
[TBL] [Abstract][Full Text] [Related]
10. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.
Jha RK; Khan RJ; Amera GM; Singh E; Pathak A; Jain M; Muthukumaran J; Singh AK
J Mol Model; 2020 Oct; 26(11):304. PubMed ID: 33068184
[TBL] [Abstract][Full Text] [Related]
11. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
[TBL] [Abstract][Full Text] [Related]
12. UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments.
Gautam A; Rishi P; Tewari R
Appl Microbiol Biotechnol; 2011 Oct; 92(2):211-25. PubMed ID: 21822642
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomics study for the identification of drug and vaccine targets in Staphylococcus aureus: MurA ligase enzyme as a proposed candidate.
Ghosh S; Prava J; Samal HB; Suar M; Mahapatra RK
J Microbiol Methods; 2014 Jun; 101():1-8. PubMed ID: 24685600
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel non-homologous drug targets against Acinetobacter baumannii using subtractive genomics and comparative metabolic pathway analysis.
Kaur H; Kalia M; Taneja N
Microb Pathog; 2021 Mar; 152():104608. PubMed ID: 33166618
[TBL] [Abstract][Full Text] [Related]
15. In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii.
Verma P; Tiwari M; Tiwari V
J Biomol Struct Dyn; 2018 Apr; 36(5):1182-1194. PubMed ID: 28393677
[TBL] [Abstract][Full Text] [Related]
16. Computer aided ligand based screening for identification of promising molecules against enzymes involved in peptidoglycan biosynthetic pathway from Acinetobacter baumannii.
Amera GM; Khan RJ; Pathak A; Jha RK; Muthukumaran J; Singh AK
Microb Pathog; 2020 Oct; 147():104205. PubMed ID: 32353580
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling and bioinformatical analysis of the antibacterial target enzyme MurA from a drug design perspective.
Klein CD; Bachelier A
J Comput Aided Mol Des; 2006; 20(10-11):621-8. PubMed ID: 17124631
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA.
Mendgen T; Scholz T; Klein CD
Bioorg Med Chem Lett; 2010 Oct; 20(19):5757-62. PubMed ID: 20729083
[TBL] [Abstract][Full Text] [Related]
19. Avenaciolides: potential MurA-targeted inhibitors against peptidoglycan biosynthesis in methicillin-resistant Staphylococcus aureus (MRSA).
Chang CM; Chern J; Chen MY; Huang KF; Chen CH; Yang YL; Wu SH
J Am Chem Soc; 2015 Jan; 137(1):267-75. PubMed ID: 25521652
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F.
Hrast M; Sosič I; Sink R; Gobec S
Bioorg Chem; 2014 Aug; 55():2-15. PubMed ID: 24755374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
